Key Dates

Related Announcements

RFA-OD-19-029 - The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to inform potential applicants that the National Heart, Lung, and Blood Institute (NHLBI) is participating, effective immediately, in Funding Opportunity Announcement (FOA) RFA-OD-19-029 "The Intersection of Sex and Gender Influences on Health and Disease (R01 Clinical Trial Optional)".

The following sections of RFA-OD-19-029 have been updated to reflect the participation of NHLBI in this FOA.

Part 1. Overview Information

The following information has been added:

Components of Participating Organizations

Office of Research on Women’s Health (ORWH)
All applications to this funding opportunity announcement should fall within the mission of the Institutes/Centers. ORWH and SGMRO may co-fund applications assigned to those Institutes/Centers. National Center for Complementary and Integrative Health (NCCIH)
National Human Genome Research Institute (NHGRI)
National Institute on Aging (NIA)
National Institute on Alcohol Abuse and Alcoholism (NIAAA)
National Institute of Allergy and Infectious Diseases (NIAID)
National Institute on Drug Abuse (NIDA)
National Institute of Dental and Craniofacial Research (NIDCR)
National Institute of Environmental Health Sciences (NIEHS)
National Institute of Mental Health (NIMH)
National Institute of Nursing Research (NINR)
Sexual & Gender Minority Research Office (SGMRO)
National Heart, Lung, and Blood Institute (NHLBI)

Catalog of Federal Domestic Assistance (CFDA) Number(s)

93.313, 93.213, 93.172, 93.866, 93.273, 93.855, 93.279, 93.121, 93.113, 93.361, 93.242, 93.837, 93.838, 93.939, 93.840, 93.233

Part 2. Section I. Funding Opportunity Description

The following information has been added:

Areas of Interest of Participating Institutes, Centers and Offices

National Heart, Lung, and Blood Institute (NHLBI)
The NHLBI is interested in supporting research to understand mechanisms of heart (and vascular), lung, hematologic (blood), and sleep (HLBS) diseases/disorders that present only in women, are more prevalent in women than in men, or have different presentation, manifestation, outcomes or treatment effects in women as compared with men as well as their interaction with the broader environment. NHLBI is interested in applications that include, but are not limited to, multidisciplinary approaches that are relevant across more than one HLBS areas. In addition, the NHLBI is especially interested in applications that address topics relevant to its Strategic Vision.

Specific areas of interest to NHLBI include, but are not limited to, the following:

• Understanding the intersection of sex and gender in mechanisms of HLBS diseases and disorders or resilience of the entire spectrum of health/disease topics within NHLBI's mission/research priorities, and throughout women’s life course (including pregnancy and postpartum), and in women from different races/ethnicities/origins/heritage groups.
• The influence or interaction of environmental factors (including psychosocial, socioeconomic, and sociocultural determinants of health) in sex differences in mechanisms of HLBS diseases or disorders and/or resilience.
• Mechanisms of disease of non-HLBS diseases and disorders with increased or exclusive HLBS manifestation in women.
• Sex differences in HLBS diseases and disorders symptomatology, presentation, and long-term outcomes.
• Clinical trials and need for models of effective engagement and retention of women from underrepresented backgrounds.

Section VII. Agency Contacts

The following contacts have been added:

Scientific/Research Contacts

Marrah Lachowicz-Scroggins, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0222
Email: [email protected]

Financial/Grants Management

Debbie Chen
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-827-8023
Email: [email protected] 

All other aspects of this FOA remain the same.

Inquiries

Please direct all inquiries to:

Marrah Lachowicz-Scroggins, PhD
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0222
Email: [email protected]